IL22 and Alzheimer disease: However, this study has some limitations and more detailed investigations are warranted in the future to evaluate the effect of Gal-9 administration in the IL-13 and IL-22-stimulated keratinocytes, two important cytokines that regulates cellular responses in AD pathogenesis [41].